Print Version
New Drug Available to Treat Multidrug-Resistant Tuberculosis
Author:
CDC NCHHSTP Division of Tuberculosis Elimination, Centers for Disease Control and Prevention (CDC), National Center for HIV/AIDS Viral Hepatitis STD and TB Prevention, Division of Tuberculosis Elimination
Publication Date:
2014
Format:
Webpage
Language:
English
Abstract
This Medscape CDC Expert Video Commentary features Dr. Sundari Mase discussing multidrug-resistant tuberculosis (MDR TB) and the recently released CDC guidelines for the use and monitoring of a new TB drug called bedaquiline.Publisher:
CDC NCHHSTP Division of Tuberculosis Elimination
Audience(s):
Health Professionals
Topic:
MDR TB, TB Treatment
Notes:
To view the video, please register with Medscape. Registration is free.
Disclaimer: The information on the Find TB Resources Website is made available as a public service. Neither the Centers for Disease Control and Prevention nor the National Prevention Information Network endorses the organizations, Website s, and materials presented. It is the responsibility of the user to evaluate this information prior to use based on individual, community, and organizational needs and standards.